Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome

  • Kjersti Tjensvoll1,
  • Satu Oltedal1,
  • Reino Heikkilä1, 6,
  • Jan Terje Kvaløy2, 3,
  • Bjørnar Gilje1,
  • James M Reuben4,
  • Rune Smaaland1 and
  • Oddmund Nordgård1, 5Email author
BMC Cancer201212:190

DOI: 10.1186/1471-2407-12-190

Received: 3 October 2011

Accepted: 27 March 2012

Published: 28 May 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
3 Oct 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
16 Nov 2011 Reviewed Reviewer Report - Gro Wiedswang
26 Jan 2012 Author responded Author comments - Kjersti Tjensvoll
Resubmission - Version 3
26 Jan 2012 Submitted Manuscript version 3
8 Feb 2012 Reviewed Reviewer Report - Gro Wiedswang
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
27 Mar 2012 Editorially accepted
28 May 2012 Article published 10.1186/1471-2407-12-190

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Haematology and Oncology, Stavanger University Hospital
(2)
Department of Mathematics and Natural Sciences, University of Stavanger
(3)
Division of Research and Human Resources, Stavanger University Hospital
(4)
Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center
(5)
Laboratory for Molecular Biology, Department of Haematology and Oncology, Stavanger University Hospital
(6)
Roche Norge AS

Advertisement